Found: 3 articles

Article Edition
A.V. Fateeva, E.V. Eliseeva, V.I. Apanasevich, A.A. Zaemskaya
Analysis of pharmacotherapy in patients with HR+HER2- metastatic breast cancer with PIK3CA mutations in real clinical practice
№7 / 2024
Romashkina N.V., Klishina M.V., Carabina E.V.
Frequency and spectrum of PIK3CA mutations in hormone-dependent HER2-negative breast cancer: a single-center experience
№4 / 2024
V.F. Semiglazov, P.V. Krivorotko, A.V. Komyakhov, T.Yu. Semiglazova, L.P. Gigolaeva, T.T. Tabagua, M.D. Kazantseva, A.P. Tergoeva, D.G. Ulrikh, M.V. Chervyak, V.V. Klimenko, N.S. Amirov, E.K. Zhiltsova, V.V. Semiglazov
The role of alpelisib in the treatment of PIK3CA – a mutated breast cancer
№11-12 / 2022


Бионика Медиа